>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

MedWatch March 2013 Safety Labeling Changes

Monday, April 15, 2013

The MedWatch March 2013 Safety Labeling Changes posting includes 53 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT.

The "Summary Page" provides a listing of drug names and safety labeling sections revised:

 http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm346535.htm

The following drugs had modifications to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections:

Brilinta (ticagrelor)
Carafate (sucralfate)
Carafate (sucralfate)
Wellbutrin (bupropion hydrochloride) and Wellbutrin SR 
Anaprox, Anaprox DS (naproxen sodium tablets)
Avastin (bevacizumab)
Clozaril (clozapine)
Coly-Mycin M Parenteral Solution (colistimethate sodium, USP)    
EC-Naprosyn (naproxen delayed-release tablets)
Erbitux (cetuximab) 
Firmagon (degarelix for injection)
Geodon (ziprasidone HCl)
Geodon (ziprasidone mesylate)
Humalog (insulin lispro [rDNA origin] injection)
Humalog Mix 50/50 (50% insulin lispro protamine suspension/50% insulin lispro [rDNA origin] injection)
Humalog Mix 75/25 (75% insulin lispro protamine suspension/25% insulin lispro [rDNA origin] injection)
INOmax (nitric oxide) for Inhalation
Levemir (insulin detemir [rDNA origin] injection)
Lopressor (metoprolol tartrate) Tablets
Lopressor (metoprolol tartrate) injection
Maxipime (cefepime hydrochloride, USP) for Injection
Merrem I.V. (meropenem for injection)
Naglazyme (galsulfase)
Naprosyn (naproxen tablets) 
NovoLog (insulin aspart [rDNA origin] injection)
NovoLog Mix 50/50 (50% insulin aspart protamine suspension and 50% insulin aspart [rDNA origin] injection)
NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart [rDNA origin] injection)
Remicade (infliximab)
Rythmol (propafenone HCl)
Silvadene (silver sulfadiazine)
Tegretol (carbamazepine) and Tegretol-XR (carbamazepine extended-release)
Vectibix (panitumumab)
Arthrotec (diclofenac sodium/misoprostol)
Carbatrol (carbamazepine)
Cerebyx (fosphenytoin sodium)
Dilantin-125 (phenytoin)
Dilantin (phenytoin sodium, USP)
Toradol (ketorolac tromethamine)
Visicol (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP)

« Back to FDA Alerts and Recalls